Professor Philip Rowlings has over 30 years research experience in clinical trials of new treatments for blood cancer patients, and biostatistical analyses of large datasets in blood and marrow transplant, as well as health resource utilisation. He is a Conjoint Professor of Medicine, Faculty of Health, University of Newcastle, and serves on the Conjoint Academic Appointments Committee. He was Director of Haematology for Calvary Mater Newcastle and Hunter New England Health District 2010 to 2019.

Philip is an Emeritus Member of the Asia Pacific Bone Marrow Transplant (APBMT) group based in Ngoya Japan, having served on the Scientific Advisory Committee for many years, and co-organising the Annual International Meeting in Sydney. He has also served as an executive member of NSW BMT advisory committee, a division of the Agency for Clinical Innovation of the NSW Clinical Excellence Commission. Philip was a board member representing Australia on the World Wide Blood and Marrow Transplant Network (WBMT), and served as a Scientific Director of the Center for International Blood and Marrow Transplant Research (CIBMTR, based in Milwaukee and Minneapolis, USA) from 1992-1998, and as a member of the Scientific Advisory Committee until 2014, including a 3 year period as a founding Co-Chair of the International Studies Committee.

Philip participated in the early ALSG AML clinical trials in the 1980s as a Registrar, and following his return from the USA in 1998, was an interested participant at the unification of the ALSG and ANZLG to become ALLG. He developed the initial protocols and was the founding Chairman of the ALLG SDMC. He has been a Local PI on many ALLG studies over the last 20 years.

Publications in order of frequency of citation may be found here.